Statistics on Biotechnology Use  
Business Sector
Biotechnology indicators by branch of activity.
Unidades: Specified in each variable

,Total companies,Services,Industry and Construction,Agriculture,
Number of companies carrying out R&D in Biotechnology,1.444,107,455,883,
% Companies by type of biotechnology used: Genetic Code,30,7,21,5,16,8,38,9,
% Companies by type of biotechnology used: Functional Units,37,6,18,7,33,2,42,1,
% Companies by type of biotechnology used: Cell and Tissue Culture and Engineering,21,3,15,6,15,1,25,2,
% Companies by type of biotechnology used: Bioprocesses,50,9,47,5,75,7,38,6,
% Companies by type of biotechnology used: Subcellular Organisms,8,1,0,9,6,6,9,7,
% Companies by type of biotechnology used: Bioinformatics,22,6,4,7,10,2,31,2,
% Companies by type of biotechnology used: Nanobiotechnology,9,8,0,9,5,1,13,3,
% Companies by type of biotechnology used: Other,16,9,29,6,9,8,19,
Companies in which biotechnology activities are: Main and/or exclusive,629,20,111,498,
Companies in which biotechnology activities are: A secondary business line,262,17,100,145,
Companies in which biotechnology activities are: A necessary tool for production,553,70,243,240,
% Companies by final application areas of biotechnology use: Human Health,44,3,1,9,24,5,59,6,
% Companies by final application areas of biotechnology use: Animal Health and Aquaculture,15,8,17,9,13,2,16,9,
% Companies by final application areas of biotechnology use: Food Products,30,7,30,9,48,3,21,6,
% Companies by final application areas of biotechnology use: Agriculture and Forestry,24,9,65,7,22,2,21,4,
% Companies by final application areas of biotechnology use: Environment,16,9,13,2,17,2,17,2,
% Companies by final application areas of biotechnology use: Industry,12,6,6,3,13,13,1,
R&D personnel in Biotechnology (PP),17.743,1.000,5.585,11.158,
R&D personnel in Biotechnology (PP): Research personnel,9.445,293,2.218,6.934,
R&D personnel in Biotechnology (PP): Technical and auxiliary personnel,8.298,708,3.367,4.224,
R&D personnel in Biotechnology (PP). Women,9.907,356,3.102,6.449,
R&D personnel in Biotechnology (PP). Women: Research personnel,5.104,113,1.155,3.836,
R&D personnel in Biotechnology (PP). Women: Technical and auxiliary personnel,4.802,243,1.946,2.613,
R&D personnel in Biotechnology (FTE),12.993,4,616,8,3.924,1,8.452,5,
R&D personnel in Biotechnology (FTE): Research personnel,7.069,9,194,7,1.616,5.259,3,
R&D personnel in Biotechnology (FTE): Technical and auxiliary personnel,5.923,6,422,1,2.308,1,3.193,3,
R&D personnel in Biotechnology (FTE). Women,7.471,8,223,8,2.336,7,4.911,2,
R&D personnel in Biotechnology (FTE). Women: Research personnel,3.870,1,73,4,894,2.902,8,
R&D personnel in Biotechnology (FTE). Women: Technical and auxiliary personnel,3.601,6,150,5,1.442,8,2.008,4,
Expenditure on internal R&D in Biotechnology (thousands of euros),1.223.801,36.807,437.823,749.171,
1) By type of expenditure: Current expenditure,1.108.189,33.108,406.903,668.179,
1.1) Labour expenditure of research personnel,360.922,9.392,108.070,243.460,
1.2) Labour expenditure of technical and auxiliary personnel,220.540,11.866,91.401,117.272,
1.3) Other current expenditure,526.727,11.849,207.432,307.446,
2) By type of expenditure: Capital expenditure,115.612,3.699,30.921,80.993,
2.1) Land and buildings,16.843,1.812,2.957,12.074,
2.2) Equipment and tools,63.527,1.809,22.909,38.809,
2.3) Acquisition of specific R&D software,3.959,61,841,3.057,
2.4) Other R&D-specific IP products,31.284,17,4.214,27.054,
1.1) By origin of funds: Own funds,860.603,34.837,371.804,453.963,
1.2) By origin of funds: Funds from the Business sector,128.002,84,5.242,122.675,
1.3) By origin of funds: Funds from the Public Administration sector,119.498,1.832,17.353,100.313,
1.4) By origin of funds: Funds from the Higher Education sector,647,0,9,638,
1.5) By origin of funds: Funds from the Private Non-Profit Institutions sector,12.986,0,19,12.966,
1.6) By origin of funds: Funds from the rest of the world,102.065,54,43.395,58.617,
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros),123.396,775,74.871,47.750,
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In Spain,88.985,775,63.502,24.707,
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In the rest of the world,34.412,0,11.368,23.043,
% Companies that consider the following obstacles to the development of biotechnologies as very important: Access to capital,39,8,31,1,28,2,46,8,
% Companies that consider the following obstacles to the development of biotechnologies as very important: Access to technology/information,15,3,15,3,18,5,13,6,
% Companies that consider the following obstacles to the development of biotechnologies as very important: Access to human resources,22,3,24,6,20,8,22,8,
% Companies that consider the following obstacles to the development of biotechnologies as very important: Disconnection from the value chain,12,1,8,1,11,5,12,9,
% Companies that consider the following obstacles to the development of biotechnologies as very important: Lack of access to international markets,17,1,8,1,12,2,20,7,
% Companies that consider the following obstacles to the development of biotechnologies as very important: Lack of distribution and marketing channels,17,8,11,14,6,20,3,
% Companies that consider the following obstacles to the development of biotechnologies as very important: Public acceptance/perception,16,14,9,16,5,15,8,
% Companies that consider the following obstacles to the development of biotechnologies as very important: Legal and regulatory requirements,41,4,49,39,6,41,5,
% Companies that consider the following obstacles to the development of biotechnologies as very important: Time/cost,50,2,51,3,50,5,50,
% Companies that consider the following obstacles to the development of biotechnologies as very important: Difficult access to patenting,20,1,25,4,17,2,20,9,
% Companies with international revenues related to biotechnology activities,22,7,8,1,22,3,24,7,
% Companies representing international revenues related to biotechnology activities,2,1,4,6,1,9,3,5,
% International revenues related to biotechnology activities distributed in: Revenues from the EU,60,6,88,4,63,46,9,
% International revenues related to biotechnology activities distributed in: Revenues from the rest of the world,39,4,11,6,37,53,1,
% International revenues related to biotechnology activities by classification: International trade in goods and services,87,8,100,88,6,82,7,
% International revenues related to biotechnology activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain,10,1,0,10,7,8,8,
% International revenues related to biotechnology activities by classification: Subsidies from external sources,1,4,0,0,6,4,9,
% International revenues related to biotechnology activities by classification: Other,0,8,0,0,1,3,6,
Notas:
Data referring to all companies that carry out internal R&D in Biotechnology.
 2) ' .'= numeric data equal to zero not resulting from rounding
 3) FTE: Full-Time Equivalence
Fuente: National Statistics Institute